Trials / Completed
CompletedNCT02087566
Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
Single-Dose Linezolid Pharmacokinetics In Critically Ill Patients With Impaired Renal Function Especially Chronic Haemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Damanhour University · Academic / Other
- Sex
- Male
- Age
- 22 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Renal failure patients were treated with linezolid (LZD) for proven or suspected infections by multiresistant Gram-positive cocci. The aim of this study is to determine if dose adjustment of LZD is needed as a function of renal impairment or not, especially that a significant component of LZD is eliminated unchanged in urine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 600 mg linezolid |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2014-03-14
- Last updated
- 2014-03-14
Source: ClinicalTrials.gov record NCT02087566. Inclusion in this directory is not an endorsement.